LGALS1 and type 2 diabetes mellitus: MR analyses of the effect of galectin-1 among the four subgroups of type 2 diabetes showed that, among the SIRD group, genetically elevated levels of galectin-1 were positively associated with eGFR (p = 5.7 × 10−3; Fig. 3b).